Vnitr Lek 1999, 45(8):487-489

[Leukemic transformation of polycythemia vera after treatment with hydroxyurea and chromosome 17 abnormalities].

E Tóthová, E Nebesnáková, A Kafková, N Stecová, M Fricová
Klinika hematológie LF UPJS, Kosice.

The authors present two patients with polycythemia vera where they recorded after several years' treatment with hydroxyurea development of acute myeloblastic leukaemia. In both instances they found, associated with leukaemia, abnormalities of chromosome no.17, in one case meeting criteria of the so-called 17p-syndrome. Progression of polycythemia vera into acute leukaemia is explained by the possible association with the long-term use of the drug and loss of chromosomal material (short arm of chromosome 17), the part where genes important in the process of leukaemogenesis are located. The authors draw attention to contemplated long-term administration of hydroxyurea to young patients with polycythemia vera. As cytogenetic analysis is a suitable method for evidence of progressing polycythemia vera into acute leukaemia, dynamic follow up of chromosomal changes is necessary, in particular in patients where long-term treatment with hydroxyurea is assumed.

Keywords: Chromosome Deletion; Chromosomes, Human, Pair 17 /genetics/; Female; Humans; Hydroxyurea /adverse effects/; Leukemia, Myeloid, Acute /etiology/; Middle Aged; Polycythemia Vera /complications/

Published: August 1, 1999  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tóthová E, Nebesnáková E, Kafková A, Stecová N, Fricová M. [Leukemic transformation of polycythemia vera after treatment with hydroxyurea and chromosome 17 abnormalities]. Vnitr Lek. 1999;45(8):487-489.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.